EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase I)

A Phase I Study of TRK-250, a Novel siRNA-Based Oligonucleotide, in Patients with Idiopathic Pulmonary Fibrosis

Hiroyuki Doi iD, Jun Atsumi, David Baratz, Yohei Miyamoto

Journal of Aerosol Medicine and Pulmonary Drug Delivery · 01.12.2023 · 36 (6) · 300-308

DOI: 10.1089/jamp.2023.0014 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Aerosol Medicine and Pulmonary Drug Delivery, erschienen am 01.12.2023. Verfasst von Hiroyuki Doi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Department, Toray Industries, Inc., Tokyo, Japan. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Idiopathic Pulmonary FibrosisHumansRNA, Small InterferingAdministration, InhalationLungCoughDouble-Blind MethodTreatment Outcome

Stichwörter der Autor:innen

Phase I StudyTGF-β1idiopathic pulmonary fibrosisinhalationsiRNA

Substanzen

RNA, Small Interfering

Autor:innen und Institutionen

  • Clinical Research Department, Toray Industries, Inc., Tokyo, Japan.
  • Pulmonary Associates, Phoenix, Arizona, USA.

ORCID-Profile: Hiroyuki Doi

Zitieren

APA

Doi, H., Atsumi, J., Baratz, D., & Miyamoto, Y. (2023). A Phase I Study of TRK-250, a Novel siRNA-Based Oligonucleotide, in Patients with Idiopathic Pulmonary Fibrosis. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 36(6), 300-308. https://doi.org/10.1089/jamp.2023.0014

Vancouver

Doi H, Atsumi J, Baratz D, Miyamoto Y. A Phase I Study of TRK-250, a Novel siRNA-Based Oligonucleotide, in Patients with Idiopathic Pulmonary Fibrosis. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2023;36(6):300-308. doi:10.1089/jamp.2023.0014

BibTeX
@article{Doi2023,
  author = {Doi, Hiroyuki and Atsumi, Jun and Baratz, David and Miyamoto, Yohei},
  title = {A Phase I Study of TRK-250, a Novel siRNA-Based Oligonucleotide, in Patients with Idiopathic Pulmonary Fibrosis},
  journal = {Journal of Aerosol Medicine and Pulmonary Drug Delivery},
  year = {2023},
  volume = {36},
  number = {6},
  pages = {300--308},
  doi = {10.1089/jamp.2023.0014}
}
Kostenlos starten →